- 收听数
- 0
- 听众数
- 7
- 最后登录
- 2024-11-8
- QQ
- UID
- 9301
- 阅读权限
- 10
- 帖子
- 1189
- 精华
- 0
- 在线时间
- 380 小时
- 注册时间
- 2014-5-1
- 科研币
- 2
- 速递币
- 21
- 娱乐币
- 1794
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial | 链接 | http://www.sciencedirect.com/science/article/pii/S0959804914010077 |
|
|